US government launches AI-driven programs to overhaul clinical trials

The US government launches AI-driven programs to overhaul clinical trials, addressing industry concerns about US competitiveness with China.

The US government has launched four AI-driven programs through the Advanced Research Projects Agency for Health (ARPA-H) to overhaul clinical trials.

These initiatives aim to address industry concerns about US competitiveness with China.

The programs focus on modernizing clinical trial design, site activation, consent, and patient data collection.